ENDRA Life Sciences Inc. financial data

Symbol
NDRA on Nasdaq
Location
3600 Green Court, Suite 350, Ann Arbor, MI
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 485 % +57.1%
Quick Ratio 106 % -44.7%
Debt-to-equity 51.8 % +93.2%
Return On Equity -283 % -74.1%
Return On Assets -186 % -45.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 753K shares -99%
Common Stock, Shares, Outstanding 752K shares -99%
Entity Public Float 7.01M USD -31.6%
Common Stock, Value, Issued 74 USD -99%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.34M USD -41%
Selling and Marketing Expense 307K USD -61.2%
General and Administrative Expense 5.93M USD +22.6%
Operating Income (Loss) -8.58M USD +10.6%
Nonoperating Income (Expense) -845K USD -3094%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.77M USD +8.36%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.77M USD +8.36%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.82M USD
Inventory, Net 0 USD -100%
Assets, Current 1.85M USD -72.4%
Property, Plant and Equipment, Net 63.4K USD -30.9%
Operating Lease, Right-of-Use Asset 520K USD +91%
Assets 2.81M USD -73.1%
Accounts Payable, Current 282K USD -6.11%
Employee-related Liabilities, Current 111K USD -66.1%
Liabilities, Current 577K USD -57.3%
Operating Lease, Liability, Noncurrent 429K USD +336%
Liabilities 1.33M USD -7.87%
Retained Earnings (Accumulated Deficit) -106M USD -9.04%
Stockholders' Equity Attributable to Parent 1.47M USD -83.6%
Liabilities and Equity 2.81M USD -73.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.29M USD +39.7%
Net Cash Provided by (Used in) Financing Activities 146K USD -68.9%
Net Cash Provided by (Used in) Investing Activities -17.3K USD +27.4%
Common Stock, Shares Authorized 20M shares -98%
Common Stock, Shares, Issued 752K shares -99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.53M USD -8.55%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.81M USD -71.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14.9K USD +68.8%
Deferred Tax Assets, Valuation Allowance 24.6M USD +16.1%
Operating Lease, Liability 557K USD +98.3%
Depreciation 13.8K USD -9.9%
Payments to Acquire Property, Plant, and Equipment 17.3K USD -36%
Lessee, Operating Lease, Liability, to be Paid 672K USD +121%
Property, Plant and Equipment, Gross 580K USD -12%
Operating Lease, Liability, Current 128K USD -29.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 203K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 91.7K USD -9.52%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 114K USD +401%
Lessee, Operating Lease, Liability, to be Paid, Year Three 203K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 19.6M USD +17.9%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 107M USD +1.18%
Depreciation, Depletion and Amortization 34.5K USD +81.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Operating Leases, Future Minimum Payments Due 406K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%